HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melphalan/total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemia.

AuthorsDaniel J Landsburg, Dan T Vogl, John P Plastaras, Edward A Stadtmauer
JournalClinical lymphoma, myeloma & leukemia (Clin Lymphoma Myeloma Leuk) Vol. 14 Issue 6 Pg. e225-8 (Dec 2014) ISSN: 2152-2669 [Electronic] United States
PMID25172535 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Myeloablative Agonists
  • Melphalan
Topics
  • Adult
  • Female
  • Graft vs Host Disease (drug therapy, etiology)
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Leukemia, Plasma Cell (diagnosis, therapy)
  • Male
  • Melphalan (therapeutic use)
  • Middle Aged
  • Myeloablative Agonists (therapeutic use)
  • Transplantation Conditioning
  • Transplantation, Homologous
  • Treatment Outcome
  • Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: